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catalytic asymmetric cyclization  
Abstract: A total synthesis of (+)-conolidine has been achieved via the gold(I)-catalyzed cascade 
cyclization of a conjugated enyne. Remarkably, this strategy allowed for the simultaneous formation 
of the indole ring and the ethylidene-substituted piperidine moiety of (+)-conolidine under 
homogenous gold catalysis in an enantioselective manner (88–91% ee). 
 
Conolidine (1), which belongs to the C5-nor stemmadenine family of alkaloids, was first 
isolated from Tabernaemonta divaricata by Kam et al. in 2004 (Figure 1).1 This group only 
managed to isolate 0.0013 g of conolidine from the stem bark of this small flowering plant. Since 
Bohn, Micalizio, and co-workers accomplished the first asymmetric total synthesis of conolidine (1) 
in 2011, there has been considerable interest in its unique analgesic activity, which differs from that 
of many common opioids, including morphine.2 Although several efficient methods have been 
reported for the synthesis of C5-nor stemmadenine-type indoles,2-4 the development of a diversity-

















Figure 1. Stemmadenine-based alkaloids 
 
Homogeneous gold catalysis has attracted considerable attention because of the strong -
acidity of gold, as well as its potential to stabilize cationic reaction intermediates.5 The versatile 
reactivity of gold catalysts has allowed for the design of several eloquent cascade reactions for the 
direct step- and atom-economical synthesis of complex molecules.6 Nowadays, homogeneous gold 
catalysis is recognized as one of the most effective strategies for the electrophilic activation of 
alkynes for the synthesis of natural products.6f  
We recently reported the gold(I)-catalyzed bis-cyclization of conjugated diynes 2 (R' = H, –
NuH = CH2OH) as an efficient strategy for the construction of fused indoles 3 and 4 (Scheme 1).7 
In this reaction, the initial indole formation occurred via a 5-endo-dig cyclization, which was 
followed by a 7-endo-dig cyclization to give the fused indole 3 as the major product. Based on this 
reaction, we designed a strategy for the synthesis of (+)-conolidine (1) (Scheme 2, strategy I). It was 
envisaged that the known conolidine precursor 72,4 could be prepared by the gold(I)-catalyzed 
cascade cyclization of conjugated diyne 10. In this sense, the bis-cyclization reaction would allow 
for the formation of a fused indole (path a and b), which would be followed by a third cyclization to 
give the piperidine moiety. One of the potential issues with this strategy would be controlling the 
regioselectivity of the second cyclization step. In particular, the 6-exo-dig cyclization (path b) 
would need to be favored over the 7-endo-dig pathway (path b’) to allow for the introduction of the 
oxygen atom at the appropriate carbon of the product. We also designed a second strategy (strategy 
II) using a conjugated enyne 11 bearing a silyl enol ether.8 Notably, this strategy would avoid the 
need to control the regioselectivity of the second cyclization described in strategy I by introducing 
the oxygen atom of the conolidine as a silyl ether. It was also envisaged that the nucleophilicity of 
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the enol ether would be increased following the formation of the indole, leaving it better equipped 
to promote the subsequent formation of the piperidine ring. Furthermore, the use of a chiral 
auxiliary (in strategy I) or chiral gold complex would allow for the asymmetric induction of these 
key steps. Both of these strategies involve the use of readily accessible synthons 12–16, and can 
therefore be considered as diversity-oriented convergent syntheses. Herein, we report the total 
synthesis of (+)-conolidine (1) based on the catalytic asymmetric cyclization of the enol ether-type 
substrate 11 (strategy II). 
 

























Scheme 2. Retrosynthetic Analysis of Conolidine Based on the Gold(I)-Catalyzed Cascade 














































































Strategy I. We initially conducted a series of model experiments using conjugated diynes 2a–c 
to evaluate the possibility of controlling the regioselectivity in strategy I (Scheme 3). The reaction 
of 2a bearing a phenylglycinol moiety gave the desired isomer 4a as a minor product (4a/3a = 
29:71). In contrast, substrate 2b bearing a vicinal phenyl group and substrate 2c bearing a 
carboxylic acid preferentially afforded the corresponding 6-exo-products (4/3 = 71:29–80:20). 
Based on these results, we prepared the corresponding alcohol and carboxylic acid substrates 10a 
and 10b as the most suitable candidates for the synthesis of conolidine. 
 











































a The erythro-isomer of ()-2b was used. 
 
Our initial efforts towards the preparation and subsequent gold(I)-catalyzed cyclization of the 
conjugated diynes 10a and 10b are shown in Scheme 4. The alkylation of tosylamide 179 with 1-
bromobut-2-yne (18) gave diyne 19. The iodination of the terminal alkyne moiety in 19 with NIS 
and AgNO3, followed by the subsequent Cadiot–Chodkiewicz coupling10 of the resulting 
iodoalkyne with 13a or 13b gave the amino alcohol- and amino acid-type substrates (±)-10a and 
10b (after hydrolysis), respectively. Unfortunately, however, the subsequent reaction of 10a with 
IPrAuCl/AgOTf (10 mol %) and EtOH (2 equiv) in 1,2-DCE at 50 °C for 2 h gave a complex 
mixture of unidentified products. In contrast, the reaction of 10b under the same conditions led to 
the formation of the bis-cyclization products 20b and 20b’ with good regioselectivity for the former 
of these two products (20b/20b’ = 90/10). It is noteworthy, however, that these compounds were 
formed in low yields (<31%) because of their poor stability. Disappointingly, all of our other 
attempts to promote the formation of the piperidine using 10b and 20b/20b’ resulted in failure, 
most likely because of the poor nucleophilicity of the enol ether moiety of 20b bearing an electron-
withdrawing group. Based on these results, we discarded strategy I and focused our efforts on 
strategy II using the conjugated enynes 11a and 11b. 
 
Scheme 4. Unsuccessful Attempts at the Gold(I)-Catalyzed Cyclization of the Conjugated 


















































13a: R = H, R' = Ph, R'' = H







Strategy II. Conjugated enynes 11a and 11b bearing different silyl enol ether moieties were 
prepared according to route shown in Scheme 5. The alkylation of tosylamide 2111 with ethyl 4-
bromobutanoate (22) gave ester 23, which was reduced with DIBAL to give the corresponding 
aldehyde. The subsequent 1,2-addition of lithium (trimethylsilyl)acetylide (15) to this aldehyde, 
followed by the removal of the TMS group with TBAF afforded the terminal alkyne 25 in excellent 
yield. The Sonogashira coupling reaction of alkyne 25 with o-iodoaniline (16) provided 
alkynylaniline 26 in 90% yield. The oxidation of 26 with MnO2 gave the corresponding ketone 27 
in 71% yield, which was treated with TIPSOTf or TBSOTf in the presence of Et3N to give the 
conjugated enyne-type silyl enol ethers 11a and 11b in 75 and 81% yields, respectively. It is 
noteworthy that the (E)- and (Z)-isomers12 of 11 could be separated, as necessary, by column 
chromatography over silica gel followed by PTLC (see Supporting Information). 
 











24: R = TMS


















11a : Si = TIPS  
(75%, Z/E = 85:15)
11b : Si = TBS


























Tables  1 & 2
 
 
We then investigated the gold(I)-catalyzed cascade reaction of the enol ether-type conjugated 
enynes 11a and 11b (Table 1). The treatment of enyne 11a with L1Au(MeCN)SbF6 (5 mol %) 
(Figure 2) in toluene-d8 at room temperature afforded the desired product 9 (16%), as well as the 
two monocyclization products 2813 (34%) and 29 (14%). To drive the reaction to completion, we 
investigated the use of an additive as a proton source as well as silyl scavenger. Fortunately, the 
addition of H2O4 improved the yields of 9 to 38% (entry 2), In contrast, the use of MeOH was less 
efficient (entry 3). The use of an IPr ligand was found to be unsuitable for this reaction (entry 4). 
Similarly, several other experiments using NaBARF8h (Figure 2) as the counter anion (entry 5), 
CD2Cl2 as a solvent (entry 6) or the TBS ether 11b as a substrate (entry 7) did not improve the yield. 
 
Table 1. Optimization of the Reaction Conditionsa 
entry Ligand additive R time (h) yield(%)
b 
9 28 29 
1 L1 – TIPS 24 16 34 14 
2 L1 H2O TIPS 24 38 – 2 
3 L1 MeOH TIPS 19 29 – 2 
4 IPr H2O TIPS 24 3 45 10 
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5 L1c H2O TIPS 24 15 5 45 
6d L1 H2O TIPS 24 16 – 43 
7 L1 H2O TBS 24 33 – - 
a Unless otherwise noted, all of these reactions were carried out using 11a (Z/E = 79:21) or 11b 
(Z/E = 71:29) with L1Au(MeCN)SbF6 or IPrAuCl (5 mol %)/AgSbF6 (5 mol %) in toluene-d8 (0.2 
M) at room temperature in the presence of an additive (1.5 equiv). b NMR yields were evaluated 
using mesitylene as an internal standard. c Using L1AuCl/NaBARF. d Using CD2Cl2 as a solvent 
instead of toluene-d8. 
 


































We then proceeded to investigate the enantioselective gold(I)-catalyzed cascade reaction of the 
conjugated enyne 11a (Table 2). Based on a related study reported by Toste and co-workers 
involving the asymmetric carbocyclization of a silyl enol ether,8h we investigated the use of 
biarylphosphine-type dinuclear chiral gold complexes to affect this reaction (Figure 2). The 
treatment of the conjugated enyne 11a with (R)-DTBM-SEGPHOS(AuCl)2 (5 mol %)/AgSbF6 (10 
mol %) resulted in the formation of the undesired ketone 29 as the major product (entry 1). The use 
of (R)-MeO-DTBM-BIPHEP gave the desired product (S)-9 in 13% yield and 89% ee (entry 2). An 
increase in catalyst loading (10 mol % for the bimetallic gold complex) led to a slight decreased in 
the yield to 10%, as well as a decrease in the ee to 76% (entry 3). Expecting that the sterically less 
hindered (Z)-isomer has better reactivity, we examined the reaction of the both isomers, (Z)- and 
(E)-11a. Interestingly, the use of (Z)-11a led to an improvement in the yield of (S)-9 to 32% (entry 
5), whereas the reaction of (E)-11a failed to afford the desired product (entry 4). Taken together, 
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these results suggested that it was only possible to generate the desired product 9 from the Z-isomer 
of 11a when a E/Z mixture of 11a was used as the substrate (entries 1–3). The use of 11a in 
conjunction with a decreased loading of H2O (1.0 equiv) led to an improvement in the ee to 91%, 
although the yield dropped to 18% (entry 6). 
 
Table 2. Enantioselective Gold(I)-Catalyzed Cyclizationa 
entry Z/E (11) catalyst 
time  
(h) 
yield of  
9 (%)b 
% eec  
[(S)-9] 
1 53/47 (R)-DTBM-SEGPHOS(AuCl)2/AgSbF6 24 N.D.d,e – 
2 53/47 (R)-MeO-DTBM-BIPHEP(AuCl)2/AgSbF6 19 13 89 
3f 53/47 (R)-MeO-DTBM-BIPHEP(AuCl)2/AgSbF6 19 ca.10 76 
4 E only (R)-MeO-DTBM-BIPHESP(AuCl)2/AgSbF6  20 N.D.e – 
5 Z only (R)-MeO-DTBM-BIPHEP(AuCl)2/AgSbF6 17 32 88 
6g 83/17 (R)-MeO-DTBM-BIPHEP(AuCl)2/AgSbF6 14 18 91 
a Unless otherwise noted, these reactions were carried out using 11a in toluene (0.2 M) at room 
temperature in the presence of H2O (1.5 equiv) with a catalyst loading of 5 (for the bimetallic gold 
complex) and 10 mol % (for AgSbF6). b Isolated yields. c Determined by chiral HPLC. d Ketone 29 
was obtained as the major product. e N.D. = not detected. f The catalyst loading was increased to 10 
and 20 mol %. g Using H2O (1.0 equiv). 
 
Finally, we investigated the conversion of the bis-cyclization product (S)-9 (91% ee) to (+)-
conolidine (1). The treatment of (S)-9 with Na/naphthalene resulted in the cleavage of the Ts 
protecting group to give the known conolidine precursor 7 in 60% yield (Scheme 6). According to 
the procedure reported by Bohn, Micalizio, and co-workers,2 we obtained (+)-conolidine (1) in 34% 
yield and 84% ee. The spectroscopic and specific optical rotation data for the synthetic conolidine 
were identical to those reported in the literature.1,2  
 















9: R = Ts
(91% ee) []D = +31.5 (c 0.24, CHCl3)[]D = +32 (c 0.16, CHCl3)7: R = H lit1:  
 
In conclusion, we have achieved the total synthesis of (+)-conolidine based on the gold(I)-
catalyzed cascade cyclization of a conjugated enyne. This study has shown that the feasibility of 




General Methods. For open column chromatography, silica gel or NH2 silica gel was 
employed. Thin layer chromatography was performed on TLC silica gel 60 F254 or NH2 silica gel 60 
F254 plate (layer thickness 0.25 mm), which were developed using standard visualizing agents: UV 
fluorescence (254 nm) and anisaldehyde with heating. Melting points were measured by a hot stage 
melting point apparatus (uncorrected). In 1H NMR spectra, chemical shifts are reported in δ (ppm) 
relative to TMS as internal standard. In 13C NMR spectra, chemical shifts are referenced to the 
residual solvent signal. 1H NMR spectra are tabulated as follows: chemical shift, multiplicity (b = 
broad, s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet), number of protons, and 
coupling constant(s). 
The compounds 16, 18, 22, and (R)-DTBM-SEGPHOS(AuCl)2 were obtained commercially 
and used without further purification. The known compounds S1,14 S4,15 S7,16 17,9 21,11 and (R)-
MeO-BIPHES(AuCl)217,18 were prepared according to the literature. Structures of S1–S9 are shown 
in Schemes S1–S3 (Supporting Information). 
 
Preparation of Starting Materials.  
(R)-2-Phenyl-2-({2-[(trimethylsilyl)ethynyl]phenyl}amino)ethan-1-ol (S2). The coupling of 
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S1 and trimethylsilylacetylene was carried out according to the reported method19 as follows: to a 
stirred suspension of S1 (1.42 g, 4.86 mmol), PdCl2(PhCN)2 (112 mg, 0.29 mmol) and CuI (55.6 mg, 
0.29 mmol) in dry 1,4-dioxane (10 mL) under argon were added diisopropylamine (3.4 mL, 24.2 
mmol), trimethylsilylacetylene (0.7 mL, 5.06 mmol) and tri(tert-butyl)phosphine (0.2 mL, 0.85 
mmol). After stirring at 50 °C for 12 h, the reaction mixture was diluted with EtOAc and filtered 
through a short pad of silica gel. The filtrate was concentrated in vacuo and the residue was 
chromatographed on silica gel (hexane/EtOAc = 5/1) to afford S2 (976 mg, 65%) as amber oil: 
[]29D 242 (c 0.51, CHCl3); IR (neat): 3393 (OH), 2143 (C≡C); 1H NMR (500 MHz, CDCl3) δ: 0.30 
(s, 9H), 1.69 (br s, 1H), 3.80-3.83 (br m, 1H), 3.96-4.00 (br m, 1H), 4.56-4.57 (br m, 1H), 5.52-5.53 
(br m, 1H), 6.38 (d, J = 8.6 Hz, 1H), 6.57-6.58 (m, 1H), 7.00-7.04 (m, 1H), 7.25-7.35 (m, 6H); 13C 
NMR (125 MHz, CDCl3) δ: 0.0 (3C), 59.3, 67.3, 100.7, 101.8, 108.0, 110.9, 116.6, 126.5 (2C), 
127.6, 128.7 (2C), 129.9, 131.7, 139.7, 148.4; HRMS (FAB) calcd for C19H24NOSi (MH+) 
310.1622, found 310.1620. 
(R)-2-[(2-Ethynylphenyl)amino]-2-phenylethan-1-ol (S3). The desilylation of S2 was carried 
out according to the reported method20 as follows: K2CO3 (1.08 g, 8.0 mmol) was added to the 
solution of S2 (804 mg, 2.60 mmol) in MeOH (26 mL). After stirring at room temperature for 1 h, 
the mixture was diluted with EtOAc. The organic layer was separated, washed with water and brine, 
dried over MgSO4, and concentrated in vacuo. The residue was chromatographed on silica gel 
(hexane/EtOAc = 5/1) to afford S3 (445 mg, 72%) as pale amber powder: mp 79 °C; []26D 240 (c 
1.06, CHCl3); IR (neat): 3401 (OH), 3253 (C≡CH), 2089 (C≡C); 1H NMR (500 MHz, CDCl3) δ: 
1.66 (dd, J = 7.5, 5.2 Hz, 1H), 3.50 (s, 1H), 3.82-3.87 (m, 1H), 3.97-4.03 (m, 1H), 4.60 (dd, J = 
10.4, 6.4 Hz, 1H), 5.47-5.48 (br m, 1H), 6.39 (d, J = 8.7 Hz, 1H), 6.59-6.61 (m, 1H), 7.04-7.06 (m, 
1H), 7.27-7.30 (m, 1H), 7.31-7.38 (m, 5H); 13C NMR (125 MHz, CDCl3) δ: 59.4, 67.3, 80.6, 83.3, 
106.9, 111.1, 116.8, 126.6 (2C), 127.7, 128.9 (2C), 130.2, 132.6, 139.6, 148.4; HRMS (FAB) calcd 
for C16H16NO (MH+) 238.1226, found 238.1232. 
(R)-2-Phenyl-2-{[2-(phenylbuta-1,3-diyn-1-yl)phenyl]amino}ethan-1-ol (2a). The coupling 
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of S3 and ethynylbenzene was carried out according to the reported method21 as follows: a mixture 
of S3 (432 mg, 1.82 mmol), ethynylbenzene (1.0 mL, 9.11 mmol), Cu(OAc)2ꞏH2O (36.3 mg, 0.18 
mmol) and piperidine (0.5 mL, 5.06 mmol) in CH2Cl2 (9 mL) was stirred in open atmospheric air at 
room temperature for 5 h. The reaction mixture was concentrated in vacuo and the residue was 
chromatographed on silica gel (hexane/EtOAc = 5/1) to afford 2a (349 mg, 57%) as amber oil: 
[]26D 470 (c 1.00, CHCl3); IR (neat): 3391 (OH), 2208 (C≡C), 2140 (C≡C); 1H NMR (500 MHz, 
CDCl3) δ: 1.71-1.73 (m, 1H), 3.86-3.89 (m, 1H), 3.99-4.04 (m, 1H), 4.60-4.62 (m, 1H), 5.45-5.47 
(br m, 1H), 6.38 (d, J = 8.1 Hz, 1H), 6.60-6.62 (m, 1H), 7.05-7.07 (m, 1H), 7.27-7.31 (m, 1H), 7.33-
7.39 (m, 8H), 7.56-7.57 (m, 2H); 13C NMR (125 MHz, CDCl3) δ: 59.4, 67.2, 74.0, 78.5, 79.7, 83.0, 
106.5, 111.3, 117.0, 121.8, 126.6 (2C), 127.7, 128.4 (2C), 128.8 (2C), 129.1, 130.7, 132.4 (2C), 
133.4, 139.4, 149.4; HRMS (FAB) calcd for C24H20NO (MH+) 338.1539, found 338.1537. 
(±)-(1R,2S)-2-[(2-Bromophenyl)amino]-1,2-diphenylethan-1-ol [(±)-S5]. The reaction of 2-
bromoiodobenzene and (±)-S4 was carried out according to the reported method14 as follows: a 
mixture of 2-bromoiodobenzene (0.9 mL, 7.01 mmol), (±)-S4 (1.72 g, 8.06 mmol), NaOH (600 mg, 
15.0 mmol), and CuI (35.7mg, 0.19 mmol) was stirred under argon at 90 °C for 13 h. The reaction 
mixture was diluted with EtOAc, washed water and brine, dried over Na2SO4, and concentrated in 
vacuo. The residue was chromatographed on silica gel (hexane/EtOAc = 10/1) to afford (±)-S5 
(2.06 g, 80%) as pale amber powder: mp 100 °C; IR (neat): 3398 (OH), 1321 (NH); 1H NMR (500 
MHz, CDCl3) δ: 2.37-2.39 (br m, 1H), 4.67-4.69 (m, 1H), 5.06-5.07 (m, 1H), 5.14-5.16 (br m, 1H), 
6.35 (d, J = 8.0 Hz, 1H), 6.48 (t, J = 7.7 Hz, 1H), 6.93 (t, J = 7.7 Hz, 1H), 7.11-7.12 (m, 4H), 7.23-
7.24 (m, 3H), 7.27-7.28 (m, 3H), 7.35-7.37 (m, 1H); 13C NMR (125 MHz, CDCl3) δ: 64.4, 78.0, 
110.5, 112.8, 118.0, 126.5 (2C), 127.1 (2C), 127.7, 128.0, 128.2, 128.3 (2C), 128.6 (2C), 132.2, 
139.6, 140.4, 143.9. Anal. calcd for C20H18BrNO: C, 65.23; H, 4.93; N, 3.80. Found: C, 65.48; H, 
4.89; N, 3.79. 
(±)-(1R,2S)-1,2-Diphenyl-2-({2-[(trimethylsilyl)ethynyl]phenyl}amino)ethan-1-ol [(±)-S6]. 
According to the procedure described for the preparation of S2, (±)-S5 (2.95 g, 8.01 mmol) was 
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converted to (±)-S6 (2.72 g, 88%). Column chromatography: silica gel (hexane/EtOAc = 10/1): dark 
brown oil; IR (neat): 3298 (OH), 2140 (C≡C), 1252 (NH); 1H NMR (500 MHz, CDCl3) δ: 0.31 (s, 
9H), 2.30-2.31 (br m, 1H), 4.73-4.74 (br m, 1H), 5.10-5.11 (br m, 1H), 5.57-5.58 (br m, 1H), 6.36 
(d, J = 8.0 Hz, 1H), 6.53-6.54 (m, 1H), 6.97-6.99 (m, 1H), 7.09-7.11 (m, 4H), 7.22-7.27 (m, 7H); 
13C NMR (125 MHz, CDCl3) δ: 0.0 (3C), 63.2, 76.9, 100.2, 101.7, 108.0, 110.8, 116.5, 126.3 (2C), 
127.4, 127.6 (2C), 127.7, 127.96 (2C), 128.02 (2C), 129.7, 132.0, 137.9, 139.7, 147.8; HRMS 
(FAB) calcd for C25H28NOSi (MH+) 386.1935, found 386.1927. 
(±)-(1R,2S)-2-[(2-Ethynylphenyl)amino]-1,2-diphenylethan-1-ol [(±)-13a]. According to the 
procedure described for the preparation of S3, (±)-S6 (1.44 g, 3.74 mmol) was converted into (±)-
13a (852 mg, 73%). Column chromatography: silica gel (hexane/CHCl3= from 1/1 to 1/2): amber 
oil; IR (neat): 3396 (OH), 3292 (C≡CH), 2094 (C≡C); 1H NMR (500 MHz, CDCl3) δ: 2.54-2.55 (br 
m, 1H), 3.38 (s, 1H), 4.70-4.71 (br m, 1H), 5.02-5.03 (br m, 1H), 5.44-5.45 (br m, 1H), 6.30 (d, J = 
8.6 Hz, 1H), 6.52-6.53 (m, 1H), 6.94-6.98 (m, 1H), 7.06-7.08 (m, 4H), 7.17-7.28 (m, 7H); 13C NMR 
(125 MHz, CDCl3) δ: 63.1, 77.2, 80.6, 83.1, 107.0, 111.1, 116.7, 126.6 (2C), 127.55, 127.63 (2C), 
128.0, 128.1 (2C), 128.2 (2C), 130.1, 132.4, 138.3, 139.5, 148.2; HRMS (FAB) calcd for C22H20NO 
(MH+) 314.1539, found 314.1535. 
(±)-(1R,2S)-1,2-Diphenyl-2-{[2-(phenylbuta-1,3-diyn-1-yl)phenyl]amino}ethan-1-ol [(±)-
2b]. According to the procedure described for the preparation of 2a, (±)-13a (430 mg, 1.37 mmol) 
was converted into (±)-2b (337 mg, 59%). Column chromatography: silica gel (hexane/CHCl3= 1/1 
to CHCl3 only): brown powder; mp 122–124 °C; IR (neat): 3401 (OH), 2209 (C≡C), 2141 (C≡C); 
1H NMR (500 MHz, CDCl3) δ: 2.43-2.43 (br m, 1H), 4.72-4.73 (br m, 1H), 5.05-5.06 (br m, 1H), 
5.45-5.46 (br m, 1H), 6.29 (d, J = 8.6 Hz, 1H), 6.54 (t, J = 7.4 Hz, 1H), 6.98 (t, J = 7.4 Hz, 1H), 
7.16 (d, J = 6.9 Hz, 4H), 7.26-7.30 (m, 7H), 7.36-7.41 (m, 3H), 7.59-7.60 (m, 2H); 13C NMR (125 
MHz, CDCl3) δ: 63.4, 74.1, 77.5, 78.5, 79.9, 82.9, 106.6, 111.2, 116.9, 122.0, 126.6 (2C), 127.6 
(2C), 127.8, 128.2, 128.4 (2C), 128.5 (2C), 128.6 (2C), 129.2, 130.7, 132.4 (2C), 132.9, 138.5, 
139.2, 149.3; HRMS (FAB) calcd for C30H24NO (MH+) 414.1852, found 414.1860. 
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Ethyl 2-Phenyl-2-({2-[(trimethylsilyl)ethynyl]phenyl}amino)acetate [(±)-S8]. To a stirred 
suspension of (±)-S7 (2.59 g, 6.78 mmol), PdCl2(PPh3)2 (119 mg, 0.17 mmol) and CuI (32.3 mg, 
0.17 mmol) in THF (14 mL) under argon was added trimethylsilylacetylene (1.0 mL, 7.46 mmol) 
and Et3N (4.3 mL, 33.9 mmol). After stirring at rt for 3 h, the reaction mixture was diluted with 
EtOAc and filtered through a short pad of silica gel. The filtrate was concentrated in vacuo and the 
residue was chromatographed on silica gel (hexane/CHCl3 = 3/1) to afford (±)-S8 (2.10 g, 88%) as 
amber oil: IR (neat): 2145 (C≡C), 1736 (C=O); 1H NMR (500 MHz, CDCl3) δ: 0.31 (s, 9H), 1.21 (t, 
J = 7.2 Hz, 3H), 4.13-4.16 (m, 1H), 4.23-4.26 (m, 1H), 5.09 (d, J = 5.7 Hz, 1H), 6.04-6.05 (br m, 
1H), 6.29 (d, J = 8.6 Hz, 1H), 6.58-6.59 (m, 1H), 7.02-7.03 (m, 1H), 7.30 (d, J = 6.9 Hz, 2H), 7.34-
7.36 (m, 2H), 7.50 (d, J = 6.9 Hz, 2H); 13C NMR (125 MHz, CDCl3) δ: 0.00 (3C), 14.0, 60.4, 61.7, 
100.8, 108.1, 101.5, 110.3, 116.8, 127.0 (2C), 128.2, 128.7 (2C), 129.8, 131.8, 137.4, 147.2, 171.0; 
HRMS (FAB) calcd for C21H26NO2Si (MH+) 352.1733, found 352.1726. 
Ethyl 2-[(2-Ethynylphenyl)amino]-2-phenylacetate [(±)-13b]. According to the procedure 
described for the preparation of S3, (±)-S8 (5.27 g, 15.0 mmol) was converted into (±)-13b (2.99 g, 
71%). Column chromatography: silica gel (hexane/EtOAc = 20/1) The product was recrystallized 
from CHCl3–hexane: white powder; mp 100 °C; IR (neat): 3264 (C≡CH), 2095 (C≡C), 1723 
(C=O); 1H NMR (500 MHz, CDCl3) δ: 1.22 (t, J = 7.2 Hz, 3H), 3.51 (s, 1H), 4.15 (dq, J = 11.0, 7.0 
Hz, 1H), 4.24 (dq, J = 11.0, 7.0 Hz, 1H), , 5.11 (d, J = 5.7 Hz, 1H), 6.03-6.04 (br m, 1H), 6.30 (d, J 
= 8.6 Hz, 1H), 6.61 (ddd, J = 7.4, 7.4, 1.1 Hz, 1H), 7.05-7.07 (m, 1H), 7.29-7.31 (m, 1H), 7.35-7.37 
(m, 3H), 7.49-7.51 (m, 2H); 13C NMR (125 MHz, CDCl3) δ: 14.0, 60.3, 61.9, 80.3, 83.2, 107.1, 
110.5, 117.0, 127.1 (2C), 128.3, 128.8 (2C), 130.1, 132.6, 137.3, 147.3, 171.2. Anal. calcd for 
C18H17NO2: C, 77.40; H, 6.13; N, 5.01. Found: C, 77.36; H, 6.11; N, 5.00. 
Ethyl 2-{[2-(Hepta-1,3-diyn-1-yl)phenyl]amino}-2-phenylacetate [(±)-S9]. According to the 
procedure described for the preparation of 2a, (±)-13b (836 mg, 3.0 mmol) was converted into S9 
(621 mg, 60%). Column chromatography: silica gel (hexane/EtOAc = 10/1): brown powder; mp 
83–84 °C; IR (neat): 2236 (C≡C), 2139 (C≡C), 1733 (C=O); 1H NMR (500 MHz, CDCl3) δ: 1.04 (t, 
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J = 7.4 Hz, 3H), 1.23 (t, J = 7.2 Hz, 3H), 1.63 (qt, J = 7.4, 7.2 Hz, 2H), 2.37 (t, J = 7.2 Hz, 2H), 
4.14-4.27 (m, 2H), 5.09 (d, J = 6.3 Hz, 1H), 5.99-6.00 (br m, 1H), 6.28 (d, J = 8.0 Hz, 1H), 6.58-
6.59 (m, 1H), 7.02-7.04 (m, 1H), 7.32-7.34 (m, 4H), 7.50 (d, J = 7.4 Hz, 2H); 13C NMR (125 MHz, 
CDCl3) δ: 13.6, 14.0, 21.7, 21.8, 60.4, 61.9, 65.2, 71.2, 80.3, 86.0, 107.1, 110.6, 117.1, 127.1 (2C), 
128.3, 128.8 (2C), 130.2, 133.3, 137.2, 148.1, 171.0; HRMS (FAB) calcd for C23H24NO2 (MH+) 
346.1802, found 346.1804. 
2-{[2-(Hepta-1,3-diyn-1-yl)phenyl]amino}-2-phenylacetic acid [(±)-2c]. To a stirred 
suspension of (±)-S9 (86.9 mg, 0.25 mmol) in EtOH (5 mL) was added THF until (±)-S9 dissolved 
(ca. 2 mL), and 0.4N NaOH aq. (19 mL) was added to the reaction mixture. After stirring at rt for 
40 min, the reaction mixture was diluted with CH2Cl2, washed with water, 1N HCl aq., and brine, 
dried over Na2SO4, and concentrated in vacuo. The residue was recrystallized from CH2Cl2–hexane 
to afford (±)-2c (43.3 mg, 54%): white solid; mp 164–166 °C; IR (neat): 3394 (OH), 2238 (C≡C), 
2147 (C≡C), 1709 (C=O); 1H NMR (500 MHz, CDCl3) δ: 1.04 (t, J = 7.4 Hz, 3H), 1.63 (qt, J = 7.4, 
6.9 Hz, 2H), 2.37 (t, J = 6.9 Hz, 2H), 5.14 (s, 1H), 6.30-6.32 (m, 1H), 6.61-6.63 (m, 1H), 7.04-7.08 
(m, 1H), 7.35-7.37 (m, 4H), 7.51-7.52 (m, 2H); 13C NMR (125 MHz, CDCl3) δ: 13.5, 21.68, 21.74, 
60.2, 65.1, 71.0, 80.4, 86.2, 107.3, 110.6, 117.6, 127.2 (2C), 128.8, 129.1 (2C), 130.3, 133.4, 136.4, 
147.8, 175.8; HRMS (FAB) calcd for C21H20NO2 (MH+) 318.1489, found 318.1485. 
N-(But-2-yn-1-yl)-N-(but-3-yn-1-yl)-4-methylbenzenesulfonamide (19). A mixture of 17 
(4.47 g, 20.0 mmol) and Cs2CO3 (16.3 g, 50.0 mmol) in dry DMF (100 mL) was stirred in open 
atmospheric air at 0 ºC. After stirring at the same temperature for 0.5 h, 1-bromobut-2-yne (18) (2.7 
mL, 29.8 mmol) was added to the mixture. The mixture was stirred for 0.5 h. The mixture was 
diluted with Et2O, washed with water and brine, dried over MgSO4, and concentrated in vacuo. The 
residue was chromatographed on silica gel (hexane/EtOAc = 5/1) to afford 19 (5.33 g, 97%) as 
colorless oil: IR (neat): 3288 (C≡CH), 2224 (C≡C), 2120 (C≡C), 1343 (S=O), 1156 (S=O); 1H 
NMR (500 MHz, CDCl3) δ: 1.58 (t, J = 2.1 Hz, 3H), 2.01 (t, J = 2.5 Hz, 1H), 2.42 (s, 3H), 2.51 (td, 
J = 7.4, 2.5 Hz, 2H), 3.35 (t, J = 7.4 Hz, 2H), 4.12 (q, J = 2.1 Hz, 2H), 7.30 (d, J = 8.0 Hz, 2H), 
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7.73 (d, J = 8.0 Hz, 2H); 13C NMR (125 MHz, CDCl3) δ: 3.2, 18.9, 21.4, 37.7, 45.3, 70.1, 71.7, 80.8, 
81.7, 127.6 (2C), 129.3 (2C), 135.9, 143.3; HRMS (FAB) calcd for C15H18NO2S (MH+) 276.1058, 
found 276.1059.  
N-(But-2-yn-1-yl)-N-[6-(2-{[(1R,2S)-2-hydroxy-1,2-diphenylethyl]amino}phenyl)hexa-3,5-
diyn-1-yl]-4-methylbenzenesulfonamide [(±)-10a]. A mixture of 19 (1.10 g, 4.0 mmol), AgNO3 
(203 mg, 1.20 mmol), and NIS (1.26 g, 5.60 mmol) in acetone (100 mL) was stirred in open 
atmospheric air at room temperature under dark. After stirring at the room temperature for 1 h, the 
mixture was concentrated in vacuo. The residue was diluted with CHCl3, washed with water and 
brine, dried over MgSO4, and concentrated in vacuo. This crude iodide 12 was used for the next 
reaction without further purification. According to the reported method,22 the copper-mediated 
coupling of (±)-13a and 12 was conducted as follows: 12, (±)-13a (0.63 g, 2.02 mmol), and CuCl 
(60.0 mg, 0.60 mmol) in piperidine (7.0 mL) was stirred at room temperature under argon for 3 h. 
The reaction mixture was quenched with aqueous saturated NH4Cl, diluted with Et2O, washed with 
brine, dried over Na2SO4, and concentrated in vacuo. The residue was chromatographed on silica 
gel (hexane/EtOAc =10/1) to afford (±)-10a (0.31 g, 19% based on (±)-13a) as pale amber 
amorphous: IR (neat): 3396 (OH), 2230 (C≡C), 2214 (C≡C), 1327 (S=O), 1157 (S=O); 1H NMR 
(500 MHz, CDCl3) δ: 1.58 (t, J = 2.0 Hz, 3H), 2.40 (s, 3H), 2.59 (br s, 1H), 2.77 (t, J = 7.4 Hz, 2H), 
3.44 (t, J = 7.4 Hz, 2H), 4.14-4.15 (br m, 2H), 4.69-4.70 (br m, 1H), 5.07 (br s, 1H), 5.48-5.49 (br m, 
1H), 6.26 (d, J = 8.6 Hz, 1H), 6.51 (t, J = 7.2 Hz, 1H), 6.94-6.97 (m, 1H), 7.11-7.11 (m, 4H), 7.24-
7.28 (m, 9H), 7.75 (d, J = 8.0 Hz, 2H); 13C NMR (125 MHz, CDCl3) δ: 3.3, 20.3, 21.4, 37.9, 45.2, 
63.1, 67.0, 71.7, 72.5, 77.2, 79.8, 81.8, 81.9, 106.3, 111.1, 116.7, 126.5 (2C), 127.55, 127.58 (2C), 
127.7 (2C), 128.0, 128.15 (2C), 128.22 (2C), 129.4 (2C), 130.4, 132.8, 135.6, 138.3, 139.3, 143.5, 
149.3; HRMS (FAB) calcd for C37H35N2O3S (MH+) 587.2368, found 587.2363. 
Ethyl 2-{[2-(6-{[N-(But-2-yn-1-yl)-4-methylphenyl]sulfonamide}hexa-1,3-diyn-1-
yl)phenyl]amino}-2-phenylacetate [(±)-S10)]. According to the procedure described for the 
preparation of (±)-10a, (±)-13b (12.0 g, 3.0 mmol) was converted to (±)-S10 (0.80 g, 73%) by the 
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reaction with 12 in the presence of CuCl (59.4 mg, 0.6 mmol) in piperidine (7 mL) at room 
temperature for 4 h. Column chromatography: silica gel (hexane/EtOAc = 3/1); yellow oil; IR 
(neat): 2226 (C≡C), 2146 (C≡C), 1735 (C=O), 1328 (S=O), 1158 (S=O); 1H NMR (500 MHz, 
CDCl3) δ: 1.22 (t, J = 7.2 Hz, 3H), 1.61 (t, J = 2.3 Hz, 3H), 2.41 (s, 3H), 2.71-2.74 (m, 2H), 3.39-
3.42 (m, 2H), 4.12-4.27 (m, 4H), 5.09 (d, J = 5.7 Hz, 1H), 5.98 (d, J = 5.7 Hz, 1H), 6.28 (d, J = 8.6 
Hz, 1H), 6.57-6.60 (m, 1H), 7.02-7.05 (m, 1H), 7.30-7.35 (m, 6H), 7.49 (d, J = 7.4 Hz, 2H), 7.75 (d, 
J = 8.6 Hz, 2H); 13C NMR (125 MHz, CDCl3) δ: 3.3, 13.9, 20.3, 21.4, 38.0, 45.2, 60.3, 61.9, 66.8, 
71.8, 72.2, 79.8, 81.8, 81.9, 106.6, 110.6, 117.1, 127.0 (2C), 127.7 (2C), 128.3, 128.8 (2C), 129.4 
(2C), 130.4, 133.3, 135.8, 137.1, 143.4, 148.2, 170.9; HRMS (FAB) calcd for C33H33N2O4S (MH+) 
553.2161, found 553.2155. 
2-{[2-(6-{[N-(But-2-yn-1-yl)-4-methylphenyl]sulfonamide}hexa-1,3-diyn-1-
yl)phenyl]amino}-2-phenylacetic Acid [(±)-10b]. THF (ca. 2 mL) was added to the mixture (±)-
S10 (0.15 g, 0.27 mmol) and 0.4N NaOH (2 mL) in EtOH (4 mL). After stirring at the room 
temperature for 0.5 h, the reaction mixture was diluted with CH2Cl2, washed with water, 1N HCl, 
and brine, dried over Na2SO4, and concentrated in vacuo to afford (±)-10b (0.14 g, 95%) as brown 
powder; mp 64–65 °C; IR (neat): 3386 (OH), 2309 (C≡C), 2145 (C≡C), 1715 (C=O), 1326 (S=O), 
1157 (S=O); 1H NMR (500 MHz, CDCl3) δ: 1.60 (br s, 3H), 2.42 (s, 3H), 2.71-2.72 (br m, 2H), 
3.39-3.41 (br m, 2H), 4.12 (br s, 2H), 5.12 (br s, 1H), 6.31-6.32 (br m, 1H), 6.61-6.63 (m, 1H), 
7.06-7.07 (m, 1H), 7.29-7.37 (m, 7H), 7.50-7.52 (m, 2H), 7.75 (d, J = 8.0 Hz, 2H); 13C NMR (125 
MHz, CDCl3) δ: 3.3, 20.3, 21.5, 37.9, 45.1, 60.2, 66.8, 71.8, 72.2, 79.8, 81.9, 82.1, 106.6, 110.7, 
117.4, 127.2 (2C), 127.7 (2C), 128.6, 129.0 (2C), 129.4 (2C), 130.5, 133.5, 135.7, 136.5, 143.5, 
148.0, 176.0; HRMS (FAB) calcd for C31H29N2O4S (MH+) 525.1848, found 525.1849.  
Ethyl 4-{[N-(But-2-yn-1-yl)-4-methylphenyl]sulfonamide}butanoate (23). The coupling of 
21 and ethyl 4-bromobutanoate (22) was carried out according to the reported method23 as follows: 
a mixture of 21 (448 mg, 2.0 mmol) and NaH (48.0 mg, 2.4 mmol) in dry DMF (5 mL) was stirred 
at room temperature for 0.5 h under argon. 4-Bromobutanoate (22) (0.17 mL, 2.4 mmol) was added 
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to the reaction mixture. The mixture was stirred for 3 h. The mixture was quenched with aqueous 
saturated NH4Cl, diluted with EtOAc, washed with brine, dried over Na2SO4, and concentrated in 
vacuo. The residue was chromatographed on silica gel (hexane/EtOAc = 10/1) to afford 23 (0.68 g, 
100%) as pale yellow oil: IR (neat): 1730 (C=O), 1345 (S=O), 1157 (S=O); 1H NMR (500 MHz, 
CDCl3) δ: 1.26 (t, J = 7.2 Hz, 3H), 1.54 (t, J = 2.3 Hz, 3H), 1.88 (tt, J = 6.6, 6.6 Hz, 2H), 2.40-2.41 
(m, 5H), 3.21 (t, J = 6.6 Hz, 2H), 4.05 (q, J = 2.3 Hz, 2H), 4.14 (q, J = 7.2 Hz, 2H), 7.29 (d, J = 8.0 
Hz, 2H), 7.72 (d, J = 8.0 Hz, 2H); 13C NMR (125 MHz, CDCl3) δ: 3.2, 14.2, 21.5, 22.7, 31.1, 36.8, 
45.5, 60.5, 71.6, 81.6, 127.8 (2C), 129.2 (2C), 136.0, 143.2, 173.1; HRMS (FAB) calcd for 
C17H24NO4S (MH+) 338.1426, found 338.1423. 
N-(But-2-yn-1-yl)-N-[4-hydroxy-6-(trimethylsilyl)hex-5-yn-1-yl]-4-
methylbenzenesulfonamide (24). Alkynylation was carried out according to the reported method24 
as follows: to a mixture of 23 (2.70 g, 8.0 mmol) in dry CH2Cl2 (40 mL) was added 1M DIBAL in 
toluene (9 mL, 8.7 mmol) at –78 ºC under argon. After stirring at the same temperature for 1 h, the 
reaction was quenched with MeOH (1 equiv) and H2O (6 equiv) at –78 ºC, and the resulting slurry 
was allowed to warm to room temperature. It was then filtered through MgSO4 and Celite and the 
solvent was evaporated under reduced pressure to leave aldehyde 14 as a yellow liquid. This crude 
material was used for the next reaction without further purification. To a mixture of 
trimethylsilylacetylene (1 mL, 7.20 mmol) in dry THF (36 mL) at –78 ºC under argon was added n-
BuLi in THF (2.6M solution in n-BuLi; 3.1 mL, 8.0 mmol) dropwise, and the mixture was stirred at 
–78 ºC for 0.5 h to afford a solution of lithium trimethylsilylacetylide (15), to which the solution of 
14 in THF (18 mL) was slowly added. After stirring at –78 ºC for 2 h, the reaction mixture was 
cooled to room temperature, quenched with aqueous saturated NH4Cl, diluted with Et2O, washed 
with brine, dried over MgSO4, and concentrated in vacuo. The residue was chromatographed on 
silica gel (hexane/EtOAc =3/1) to afford 24 (2.81 g, 90%) as colorless oil: IR (neat): 3511 (OH), 
2223 (C≡C), 2170 (C≡C), 1345 (S=O), 1158 (S=O); 1H NMR (500 MHz, CDCl3) δ: 0.17 (s, 9H), 
1.53 (t, J = 2.3 Hz, 3H), 1.72-1.77 (m, 4H), 2.03-2.04 (br m, 1H), 2.42 (s, 3H), 3.20-3.21 (br m, 2H), 
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4.06 (q, J = 2.3 Hz, 2H), 4.42-4.43 (br m, 1H), 7.28-7.30 (m, 2H), 7.72-7.73 (m, 2H); 13C NMR 
(125 MHz, CDCl3) δ: 0.0 (3C), 3.4, 21.7, 23.1, 34.4, 36.6, 45.8, 62.5, 71.7, 81.7, 89.9, 106.4, 128.0 
(2C), 129.4 (2C), 136.1, 143.3; HRMS (FAB) calcd for C20H30NO3SSi (MH+) 392.1716, found 
392.1710. 
N-(But-2-yn-1-yl)-N-(4-hydroxyhex-5-yn-1-yl)-4-methylbenzenesulfonamide (25). To a 
mixture of 24 (4.48 g, 11.4 mmol) in dry THF (23 mL) at 0 ºC under argon was added 1M TBAF in 
THF (11.5 mL, 11.4 mmol) dropwise, and the mixture was stirred at room temperature for 0.7 h. 
The mixture was diluted with CH2Cl2, washed with water and brine, dried over Na2SO4, and 
concentrated in vacuo. The residue was chromatographed on silica gel (hexane/EtOAc =5/1) to 
afford 25 (3.42 g, 94%) as pale amber oil: IR (neat): 3516 (OH), 3284 (C≡H), 2225 (C≡C), 2114 
(C≡C), 1327 (S=O), 1156 (S=O); 1H NMR (500 MHz, CDCl3) δ: 1.54 (br s, 3H), 1.72-1.81 (m, 4H), 
2.31 (br s, 1H), 2.42 (s, 3H), 2.48-2.48 (br m, 1H), 3.21 (t, J = 6.6 Hz, 2H), 4.06-4.06 (br m, 2H), 
4.45 (br s, 1H), 7.29 (d, J = 8.0 Hz, 2H), 7.72 (d, J = 8.0 Hz, 2H); 13C NMR (125 MHz, CDCl3) δ: 
3.2. 21.4, 22.8, 34.1, 36.5, 45.6, 61.6, 71.5, 73.1, 81.6, 84.5, 127.8 (2C), 129.2 (2C), 135.8, 143.2; 
HRMS (FAB) calcd for C17H22NO3S (MH+) 320.1320, found 320.1318. 
N-[6-(2-Aminophenyl)-4-hydroxyhex-5-yn-1-yl]-N-(but-2-yn-1-yl)-4-
methylbenzenesulfonamide (26). Et3N (1.5 mL, 12.0 mmol) was added to a stirred mixture of 25 
(0.97 g, 3.02 mmol), 2-iodoaniline (16) (0.66 g, 3.03 mmol), PdCl2(PPh3)2 (53.1 mg, 0.08 mmol) 
and CuI (28.8 mg, 0.15 mmol) in CH3CN (20 mL) under argon. After stirring at room temperature 
for 1.5 h, the mixture was diluted with EtOAc, washed with aqueous saturated NH4Cl and brine, 
dried over Na2SO4, and concentrated in vacuo. The residue was chromatographed on silica gel 
(hexane/EtOAc =2/1) to afford 26 (1.11 g, 90%) as colorless oil: IR (neat): 3379 (OH), 2301 (C≡C), 
2218 (C≡C), 1328 (S=O), 1306 (NH), 1156 (S=O); 1H NMR (500 MHz, CDCl3) δ: 1.52 (t, J = 2.3 
Hz, 3H), 1.78-1.90 (m, 4H), 2.40 (s, 3H), 2.49 (br s, 1H), 3.24 (t, J = 6.6 Hz, 2H), 4.06 (q, J = 2.3 
Hz, 2H), 4.24 (br s, 2H), 4.70-4.72 (br m, 1H), 6.65-6.68 (m, 2H), 7.09-7.13 (m, 1H), 7.23-7.27 (m, 
3H), 7.72 (d, J = 8.0 Hz, 2H); 13C NMR (125 MHz, CDCl3) δ: 3.2, 21.4, 23.2, 34.6, 36.7, 45.8, 62.5, 
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71.6, 81.6, 81.7, 95.1, 107.1, 114.3, 117.8, 127.8 (2C), 129.2 (2C), 129.8, 132.2, 135.8, 143.2, 
147.9; HRMS (FAB) calcd for C23H27N2O3S (MH+) 411.1742, found 411.1742. 
N-[6-(2-Aminophenyl)-4-oxohex-5-yn-1-yl]-N-(but-2-yn-1-yl)-4-
methylbenzenesulfonamide (27). According to the reported method,25 oxidation of 26 was 
conducted as follows: a mixture of 26 (421 mg, 1.03 mmol) and MnO2 (882 mg, 10.3 mmol) in dry 
CHCl3 (10 mL) was stirred under reflux for 0.5 h. The reaction mixture was cooled to room 
temperature, filtered through Celite, and concentrated in vacuo. The residue was chromatographed 
on silica gel (hexane/EtOAc = 5/1) to afford 27 (297 mg, 71%) as orange amber oil: IR (neat): 2300 
(C≡C), 2180 (C≡C), 1658 (C=O), 1342 (S=O), 1330 (NH), 1156 (S=O); 1H NMR (500 MHz, 
CDCl3) δ: 1.54 (t, J = 2.3 Hz, 3H), 1.99 (tt, J = 7.0, 7.0 Hz, 2H), 2.41 (s, 3H), 2.82 (t, J = 7.2 Hz, 
2H), 3.22 (t, J = 6.6 Hz, 2H), 4.05 (q, J = 2.3 Hz, 2H), 4.47 (br s, 2H), 6.68-6.69 (m, 2H), 7.20-7.24 
(m, 1H), 7.28 (d, J = 8.6 Hz, 2H), 7.36-7.37 (m, 1H), 7.72 (d, J = 8.0 Hz, 2H); 13C NMR (125 MHz, 
CDCl3) δ: 3.2, 21.4, 21.9, 37.0, 42.1, 45.5, 71.5, 81.7, 89.1, 94.1, 103.4, 114.5, 117.8, 127.8 (2C), 
129.2 (2C), 132.5, 133.8, 135.7, 143.3, 105.3, 186.5; HRMS (FAB) calcd for C23H25N2O3S (MH+) 
409.1586, found 409.1590. 
(E)- and (Z)-N-{6-(2-Aminophenyl)-4-[(triisopropylsilyl)oxy]hex-3-en-5-yn-1-yl}-N-(but-2-
yn-1-yl)-4-methylbenzenesulfonamide (11a). TIPSOTf (0.9 mL, 3.24 mmol) was added dropwise 
to a mixture of 27 (883 mg, 2.16 mmol) and Et3N (0.8 mL, 6.84 mmol) in dry CH2Cl2 (36 mL) at –
78 ºC under argon, and the mixture was stirred for 2 h. The mixture allowed to warm slowly to 
room temperature. The mixture was diluted with EtOAc, washed with 3N HCl twice, water, 
aqueous saturated NaHCO3 and brine, dried over Na2SO4, and concentrated in vacuo. The residue 
was chromatographed on silica gel (hexane/EtOAc =5/1) to afford 11a (921 mg, 75%, Z/E = 85/15, 
determined by 1H NMR).11 Both products were isolated by column chromatography on silica gel 
followed by PTLC (silica gel) with hexane/EtOAc (10/1). Compound (Z)-11a (more polar isomer): 
amber oil; IR (neat): 2193 (C≡C), 1616 (SiOC=C); 1H NMR (500 MHz, CDCl3) δ: 1.12 (d, J = 7.4 
Hz, 18H), 1.27-1.36 (m, 3H), 1.54 (t, J = 2.3 Hz, 3H), 2.41 (s, 3H), 2.47-2.53 (m, 2H), 3.22 (t, J = 
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7.4 Hz, 2H), 4.09 (q, J = 2.3 Hz, 2H), 4.19 (br s, 2H), 5.09 (t, J = 7.2 Hz, 1H), 6.67-6.69 (m, 2H), 
7.11-7.14 (m, 1H), 7.21 (d, J = 6.9 Hz, 1H), 7.28 (d, J = 8.0 Hz, 2H), 7.74 (d, J = 8.0 Hz, 2H); 13C 
NMR (125 MHz, CDCl3) δ: 3.2, 12.9 (3C), 18.0 (6C), 21.5, 24.4, 36.7, 45.3, 71.8, 81.4, 83.7, 92.3, 
107.1, 114.3, 114.8, 117.8, 127.8 (2C), 129.2 (2C), 129.9, 131.9, 134.1, 136.1, 143.1, 148.0; HRMS 
(FAB) calcd for C32H45N2O3SSi (MH+) 565.2920, found 565.2919. Compound (E)-11a (less polar 
isomer): amber oil; IR (neat): 2191 (C≡C), 1616 (SiOC=C); 1H NMR (500 MHz, CDCl3) δ: 1.13 (d, 
J = 7.4 Hz, 18H), 1.27 (m, 3H), 1.51 (t, J = 2.3 Hz, 3H), 2.40 (s, 3H), 2.51-2.54 (m, 2H), 3.21 (t, J = 
7.4 Hz, 2H), 4.10 (q, J = 2.3 Hz, 2H), 4.27 (br s, 2H), 5.30 (t, J = 8.0 Hz, 1H), 6.67-6.70 (m, 2H), 
7.11-7.14 (m, 1H), 7.26-7.27 (m, 3H), 7.72 (d, J = 8.0 Hz, 2H); 13C NMR (125 MHz, CDCl3) δ: 3.2, 
12.5 (3C), 17.9 (6C), 21.5, 27.4, 37.0, 45.9, 71.8, 81.6, 89.1, 89.8, 107.0, 114.4, 114.6, 117.7, 127.8 
(2C), 129.2 (2C), 130.0, 132.1, 135.8, 136.0, 143.1, 148.0; HRMS (FAB) calcd for C32H45N2O3SSi 
(MH+) 565.2920, found 565.2913. 
(E)- and (Z)-N-{6-(2-Aminophenyl)-4-[(tert-butyldimethylsilyl)oxy]hex-3-en-5-yn-1-yl}-N-
(but-2-yn-1-yl)-4-methylbenzenesulfonamide (11b). TBSOTf (0.2 mL, 0.81 mmol) was added 
dropwise to a mixture of 27 (166 mg, 0.41 mmol) and Et3N (0.1 mL, 0.81 mmol) in dry CH2Cl2 (0.8 
mL) at 0 ºC under argon and the mixture was stirred at room temperature for 1 h. The mixture was 
diluted with EtOAc, washed with 1N HCl, water, aqueous saturated NaHCO3 and brine, dried over 
Na2SO4, and concentrated in vacuo. The residue was chromatographed on silica gel (hexane/EtOAc 
=5/1) to afford 11b (171 mg, 81%, Z/E = 73/27, determined by 1H NMR).11 Both products were 
isolated by column chromatography on silica gel followed by PTLC (silica gel) with hexane/EtOAc 
(10/1). Compound (Z)-11b (more polar isomer): reddish amber oil; IR (neat): 2193 (C≡C), 1616 
(SiOC=C); 1H NMR (500 MHz, CDCl3) δ: 0.26 (s, 6H), 0.96 (s, 9H), 1.54 (t, J = 2.3 Hz, 3H), 2.41 
(s, 3H), 2.45 (dt, J = 7.4, 7.4 Hz, 2H), 3.21 (t, J = 7.4 Hz, 2H), 4.09 (q, J = 2.3 Hz, 2H), 4.20 (br s, 
2H), 5.13 (t, J = 7.4 Hz, 1H), 6.67-6.69 (m, 2H), 7.12-7.13 (m, 1H), 7.25-7.28 (m, 3H), 7.73 (d, J = 
8.6 Hz, 2H); 13C NMR (125 MHz, CDCl3) δ: –4.1 (2C), 3.2, 18.1, 21.5, 24.3, 25.7 (3C), 36.7, 45.3, 
71.7, 81.5, 84.3, 92.1, 107.0, 114.3, 115.2, 117.8, 127.8 (2C), 129.2 (2C), 129.9, 131.9, 133.8, 
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136.0, 143.1, 147.9; HRMS (FAB) calcd for C29H39N2O3SSi (MH+) 523.2451, found 523.2458. 
Compound (E)-11b (less polar isomer): reddish amber oil; IR (neat): 2193 (C≡C), 1616 (SiOC=C); 
1H NMR (500 MHz, CDCl3) δ: 0.23 (s, 6H), 0.96 (s, 9H), 1.51 (t, J = 2.3 Hz, 3H), 2.40 (s, 3H), 2.52 
(dt, J = 7.6, 7.6 Hz, 2H), 3.22 (t, J = 7.6 Hz, 2H), 4.10 (q, J = 2.3 Hz, 2H), 4.27 (br s, 2H), 5.27 (t, J 
= 8.0 Hz, 1H), 6.66-6.70 (m, 2H), 7.11-7.14 (m, 1H), 7.25-7.29 (m, 3H), 7.72 (d, J = 8.6 Hz, 2H); 
13C NMR (125 MHz, CDCl3) δ: –4.4 (2C), 3.2, 18.1, 21.5, 25.6 (3C), 27.3, 37.0, 45.9, 71.8, 81.6, 
89.4, 89.7, 107.0, 114.4, 115.1, 117.7, 127.8 (2C), 129.2 (2C), 130.1, 132.1, 135.4, 136.0, 143.1, 
148.0; HRMS (FAB) calcd for C29H39N2O3SSi (MH+) 523.2451, found 523.2454. 
 
2. Gold(I)-Catalyzed Cascade Reactions.  
General Procedure A: Synthesis of (R)-2,5-Diphenyl-4,5-dihydro-[1,4]oxazepino[4,5-
a]indole (3a) and (R, Z)-1-Benzylidene-4-phenyl-3,4-dihydro-1H-[1,4]oxazino[4,3-a]indole (4a). 
A screw-cap test tube was charged with 2a (33.7 mg, 0.10 mmol), IPrAuCl (3.1 mg, 5.0 µmol) and 
AgOTf (1.3 mg, 5.0 µmol). Dry 1,2-DCE (1.5 mL) was added to the screw-cap test tube. After 
stirring at 50 °C for 5 h, the reaction mixture was concentrated in vacuo and chromatographed on 
NH2 silica gel (hexane/CHCl3 = 2/1), and the collected solid was rinsed with hexane to afford an 
inseparable mixture of 3a/4a (29.0 mg, 86%, 3a/4a = 71/29, determined by 1H NMR): greenish gray 
powder; mp 198–200 °C; IR (neat) 1627 (CH2OC=C); 1H NMR (500 MHz, CDCl3) δ: (Major 
isomer 3a) 4.70 (dd, J = 12.6, 1.1 Hz, 1H), 5.00 (dd, J = 12.6, 3.7 Hz, 1H), 5.89 (br m, 1H), 6.47 (s, 
1H), 6.55 (s, 1H), 7.04-7.08 (m, 3H), 7.11-7.17 (m, 2H), 7.19-7.35 (m, 6H), 7.58-7.58 (m, 1H), 
7.63-7.64 (m, 2H); (Minor isomer 4a): 4.57-4.61 (m, 2H), 5.50-5.50 (br m, 1H), 6.37 (s, 1H), 6.94 
(s, 1H), 6.98 (d, J = 8.0 Hz, 1H), 7.11-7.17 (m, 5H), 7.19-7.35 (m, 6H), 7.69 (d, J = 7.4 Hz, 2H); 
13C NMR (125 MHz, CDCl3) δ: (Major isomer 3a): 61.3, 73.3, 96.6, 102.8, 109.1, 120.19, 120.20, 
121.7, 125.5 (2C), 126.5 (2C), 127.7, 128.2 (2C), 128.3, 128.5, 128.6 (2C), 136.0, 136.6, 138.1, 
138.4, 153.4; (Minor isomer 4a): 55.3, 70.6, 97.7, 105.5, 109.6, 120.8 (2C), 122.2 (2C), 126.1 (2C), 
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127.8, 128.2 (2C), 128.3, 128.46, 128.47, 128.7, 128.9, 130.6, 135.7, 135.9, 138.1, 144.7; HRMS 
(ESI) calcd for C24H20NO (MH+): 338.1545; found: 338.1550. 
(±)-(4R,5S)-2,4,5-Triphenyl-4,5-dihydro-[1,4]oxazepino[4,5-a]indole (3b) and (±)-(3R,4S)-
1-[(Z)-Benzylidene]-3,4-diphenyl-3,4-dihydro-1H-[1,4]oxazino[4,3-a]indole (4b). By use of the 
General Procedure A, 2b (41.4 mg, 0.10 mmol) was converted to 3b/4b (37.9 mg, 92%, 3b/4b = 
29/71, determined by 1H NMR) by the reaction in the presence of IPrAuCl (3.1 mg, 5.0 µmol) and 
AgOTf (1.3 mg, 5.0 µmol) in dry 1,2-DCE (1.0 mL) at 50 °C for 2.5 h. Both the products were 
isolated by PTLC (NH2 silica gel) with hexane/Et2O (3/1). Compound 3b (less polar isomer): white 
solid; mp >250 °C; IR (neat): 1642 (CHOC=C); 1H NMR (500 MHz, CDCl3) δ: 5.90 (d, J = 6.9 Hz, 
2H), 6.61 (s, 1H), 6.64 (s, 1H), 6.82 (d, J = 6.9 Hz, 2H), 7.05-7.12 (m, 5H), 7.15-7.18 (m, 1H), 
7.23-7.24 (m, 2H), 7.32-7.36 (m, 6H), 7.59-7.60 (m, 1H), 7.69-7.70 (m, 2H); 13C NMR (125 MHz, 
CDCl3) δ: 67.5, 83.4, 97.2, 103.0, 109.2, 120.19, 120.24, 121.8, 125.7 (2C), 126.6 (2C), 127.71 
(2C), 127.73, 127.9, 128.0, 128.25 (2C), 128.34 (2C), 128.4 (2C), 128.6, 135.7, 135.9, 136.4, 138.1, 
138.4, 152.7; HRMS (FAB) calcd for C30H24NO (MH+) 414.1852, found 414.1861. Compound 4b 
(more polar isomer): pale yellow solid; mp 168–172 °C; IR (neat): 1632 (CH2OC=C); 1H NMR 
(500 MHz, CDCl3) δ: 5.54-5.55 (br m, 1H), 5.76-5.77 (br m, 1H), 6.48 (s, 1H), 6.70-6.70 (m, 2H), 
7.00 (d, J = 8.6 Hz, 1H), 7.04-7.05 (m, 2H), 7.09-7.18 (m, 7H), 7.26-7.33 (m, 5H), 7.65-7.67 (m, 
1H), 7.75 (d, J = 7.4 Hz, 2H); 13C NMR (125 MHz, CDCl3) δ: 60.9, 80.3, 97.5, 105.8, 109.1, 120.82, 
120.84, 122.3, 126.1, 126.5 (2C), 127.881 (2C), 127.886 (2C), 128.0, 128.17 (2C), 128.22, 128.35 
(2C), 128.38, 128.8 (2C), 130.3, 134.8, 135.6, 135.7, 136.2, 144.9; HRMS (FAB) calcd for 
C30H24NO (MH+) 414.1852, found 414.1859. 
5-Phenyl-2-propyl-[1,4]oxazepino[4,5-a]indol-4(5H)-one (3c) and (Z)-1-Butylidene-4-
phenyl-1H-[1,4]oxazino[4,3-a]indol-3(4H)-one (4c). By use of the General Procedure A, 2c (31.7 
mg, 0.10 mmol) was converted to 3c/4c (11.1 mg, <35%, 3c/4c = 20/80, determined by 1H NMR) 
by the reaction in the presence of IPrAuCl (3.1 mg, 5.0 µmol) and AgOTf (1.3 mg, 5.0 µmol) in dry 
1,2-DCE (1.0 mL) at 50 °C for 3 h. The products were separated by PTLC (NH2 silica gel) with 
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hexane/ Et2O (3/1). Compound 3c (less polar isomer): unstable pale amber oil; IR (neat): 1749 
(C=O); 1H NMR (500 MHz, CDCl3) δ: 0.62 (t, J = 7.4 Hz, 3H), 1.10-1.19 (m, 1H), 1.33-1.43 (m, 
1H), 1.95-2.01 (m, 1H), 2.11-2.17 (m, 1H), 5.96 (s, 1H), 6.55 (s, 1H), 6.67-6.69 (m, 2H), 6.76 (s, 
1H), 7.19-7.29 (m, 5H), 7.43 (d, J = 8.0 Hz, 1H), 7.67 (d, J = 7.4 Hz, 1H); 13C NMR (125 MHz, 
CDCl3) δ: 13.0, 19.9, 37.0, 62.9, 102.3, 102.9, 108.7, 120.8, 121.1, 122.6, 124.6 (2C), 128.5, 128.9 
(3C), 132.3, 133.0, 136.9, 149.0, 164.2; HRMS (FAB) calcd for C21H20NO2 (MH+) 318.1489, found 
318.1484. Compound 4c (more polar isomer): unstable yellow oil; IR (neat): 1760 (C=O); 1H NMR 
(500 MHz, CDCl3) δ: 0.93 (t, J = 7.4 Hz, 3H), 1.47-1.51 (m, 2H), 2.29-2.41 (m, 2H), 5.69 (t, J = 7.7 
Hz, 1H), 6.24 (s, 1H), 6.82 (s, 1H), 7.04-7.06 (m, 3H), 7.10-7.17 (m, 2H), 7.28-7.28 (m, 3H), 7.63 
(d, J = 7.4 Hz, 1H); 13C NMR (125 MHz, CDCl3) δ: 13.7, 22.4, 26.6, 59.2, 97.5, 109.7, 112.4, 121.0, 
121.4, 122.8, 126.1 (2C), 127.1, 129.0, 129.1, 129.2 (2C), 134.65, 134.74, 139.5, 163.1; HRMS 
(FAB) calcd for C21H20NO2 (MH+) 318.1489, found 318.1484. 
(Z)-N-(But-2-yn-1-yl)-4-methyl-N-[3-(3-oxo-4-phenyl-3,4-dihydro-1H-[1,4]oxazino[4,3-
a]indol-1-ylidene)propyl]benzenesulfonamide (20b). A screw-cap test tube was charged with (±)-
10b (52.5 mg, 0.1 mmol), IPrAuCl (6.2 mg, 0.01 mmol) and AgOTf (2.6 mg, 0.01 mmol). Dry 1,2-
DCE (1 mL) was added to the screw-cap test tube. After stirring at 50 °C for 27 h, the mixture was 
concentrated in vacuo and chromatographed on NH2 silica gel (hexane/CHCl3 = 3/1) to afford 
20b/20b’ (16.3 mg, <31%, 20b/20b’ = 90/10, determined by 1H NMR) as an isomeric mixture of 
unstable compounds. The major isomer 20b was isolated by PTLC (silica gel) with hexane/Et2O 
(3/1): unstable yellow oil; IR (neat): 2225 (C≡C), 1765 (C=O), 1345 (S=O), 1157 (S=O); 1H NMR 
(500 MHz, CDCl3) δ: 1.53 (t, J = 2.3 Hz, 3H), 2.40 (s, 3H), 2.61-2.65 (m, 2H), 3.33-3.34 (m, 2H), 
3.99-4.10 (m, 2H), 5.73 (t, J = 7.4 Hz, 1H), 6.25 (s, 1H), 6.87 (s, 1H), 7.05-7.07 (m, 3H), 7.11-7.17 
(m, 2H), 7.27-7.30 (m, 5H), 7.64-7.66 (m, 1H), 7.72 (m, 2H); 13C NMR (125 MHz, CDCl3) δ: 3.2, 
21.5, 23.0, 36.7, 45.2, 59.2, 71.5, 81.9, 98.5, 107.6, 109.7, 121.3, 121.5, 123.06, 126.13 (2C), 126.4, 
127.8 (2C), 128.9, 129.2, 129.27 (2C), 129.31 (2C), 134.65, 134.71, 135.9, 140.9, 143.3, 162.8; 
HRMS (FAB) calcd for C31H29N2O4S (MH+) 525.1848, found 525.1851. 
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Gold(I)-Catalyzed Cyclization of the Conjugated Enyne (Table 1): (E)-(3-Ethylidene-1-
tosylpiperidin-4-yl)(1H-indol-2-yl)methanone [(±)-9]. The experiments shown in Table 1 were 
carried out as follows: 11a (56.5 mg, 0.1 mmol; Z/E = 79:21) or 11b (52.3 mg, 0.1 mmol; Z/E = 
71:29) were treated with JohnPhosAu(MeCN)SbF6 (3.9 mg, 5.0 µmol) or IPrAuCl (3.1 mg, 5.0/5.0 
µmol; 5 mol %)/AgSbF6 (1.7 mg, 5.0 µmol; 5 mol %) in toluene-d8 (0.5 mL, 0.2 M) at room 
temperature in the presence of an additive (1.5 equiv) and mesitylene (1.0 equiv) as an internal 
standard. After completion of the reaction (monitored by TLC), the reaction mixtures were analyzed 
by 1H NMR to determine the yields of (±)-9, 28, and 29 based on the internal standard. Pure (±)-9 
was obtained as follows: a screw-cap test tube was charged with 11a (293 mg, 0.52 mmol, Z/E = 
93/7) and JohnPhosAu(MeCN)SbF6 (20 mg, 25.9 µmol). H2O (14 µL, 0.8 mmol) and dry toluene 
(2.6 mL) were added to the mixture. After stirring at room temperature for 24 h, the mixture was 
concentrated in vacuo and chromatographed on NH2 silica gel (hexane/EtOAc = 5/1). The product 
was recrystallized from CHCl3–hexane to afford (±)-9 (64.1 mg, 30%) as white solid: mp 183–
186 °C; IR (neat): 3343 (NH), 1643 (C=O), 1341 (S=O), 1162 (S=O); 1H NMR (500 MHz, CDCl3) 
δ: 1.72 (dd, J = 6.9, 1.7 Hz, 3H), 2.06-2.11 (m, 1H), 2.15-2.16 (m, 1H), 2.44 (s, 3H), 2.86 (ddd, J = 
12.2, 12.0, 3.2 Hz, 1H), 3.43-3.45 (br m, 1H), 3.71-3.74 (br m, 1H), 4.09-4.11 (br m, 1H), 4.43-4.43 
(br m, 1H), 5.72 (q, J = 6.7 Hz, 1H), 7.14-7.17 (m, 1H), 7.25 (d, J = 2.3 Hz, 1H), 7.33-7.36 (m, 4H), 
7.66 (d, J = 8.0 Hz, 2H), 7.70 (d, J = 9.2 Hz, 1H), 8.86 (br s, 1H); 13C NMR (125 MHz, CDCl3) δ: 
13.3, 21.6, 28.5, 41.2, 43.2, 52.3, 109.4, 112.0, 121.2, 123.2, 124.8, 126.7, 127.4, 127.7 (2C), 129.7 
(2C), 129.9, 133.5, 133.8, 137.3, 143.5, 192.6; HRMS (FAB) calcd for C23H25N2O3S (MH+) 
409.1586, found 409.1577. 
(Z)-N-{4-(1H-Indol-2-yl)-4-[(triisopropylsilyl)oxy]but-3-en-1-yl}-N-(but-2-yn-1-yl)-4-
methylbenzenesulfonamide (28). Amber oil: IR (neat): 3386 (NH), 2225 (C≡C), 1650 (SiOC=C), 
1341 (S=O), 1157 (S=O); 1H NMR (500 MHz, CDCl3) δ: 1.09 (d, J = 6.9 Hz, 18H), 1.18-1.21 (m, 
3H), 1.56 (t, J = 2.3 Hz, 3H), 2.40 (s, 3H), 2.54 (q, J = 7.3 Hz, 2H), 3.27 (t, J = 7.4 Hz, 2H), 4.11 (q, 
J = 2.3 Hz, 2H), 5.13 (t, J = 6.9 Hz, 1H), 6.54-6.54 (br m, 1H), 7.08-7.10 (m, 1H), 7.16-7.18 (m, 
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1H), 7.26 (d, J = 8.0 Hz, 2H), 7.33 (d, J = 8.0 Hz, 1H), 7.57 (d, J = 7.4 Hz, 1H), 7.74 (d, J = 8.6 Hz, 
2H), 8.15 (br s, 1H); 13C NMR (125 MHz, CDCl3) δ: 3.3, 13.6 (3C), 17.9 (6C), 21.5, 24.5, 36.8, 
45.8, 71.8, 81.5, 100.1, 106.4, 110.8, 119.9, 120.6, 122.2, 127.8 (2C), 128.5, 129.2 (2C), 135.7, 
136.0, 136.7, 143.2, 144.8; HRMS (FAB) calcd for C32H45N2O3SSi (MH+) 565.2920, found 
565.2927. 
N-[4-(1H-Indol-2-yl)-4-oxobutyl]-N-(but-2-yn-1-yl)-4-methylbenzenesulfonamide (29). 
White powder: mp 120–121 °C; IR (neat): 3326 (NH), 2224 (C≡C), 1649 (C=O), 1340 (S=O), 1157 
(S=O); 1H NMR (500 MHz, CDCl3) δ: 1.53 (t, J = 2.3 Hz, 3H), 2.01-2.07 (m, 2H), 2.41 (s, 3H), 
3.08 (t, J = 7.4 Hz, 2H), 3.30 (t, J = 6.9 Hz, 2H), 4.08-4.08 (br m, 2H), 7.15-7.17 (m, 1H), 7.25-7.28 
(m, 3H), 7.34-7.36 (m, 1H), 7.41-7.43 (m, 1H), 7.72-7.74 (m, 3H), 9.01 (br s, 1H); 13C NMR (125 
MHz, CDCl3) δ: 3.2, 21.4, 22.0, 34.9, 36.9, 45.8, 71.7, 81.7, 109.4, 112.1, 120.9, 123.1, 126.3, 
127.6, 127.8 (2C), 129.3 (2C), 134.9, 135.9, 137.1, 143.3, 192.2; HRMS (FAB) calcd for 
C23H25N2O3S (MH+) 409.1586, found 409.1590. 
Enantioselective Cyclization of Conjugated Enyne (Table 2): Synthesis of  (S,E)-(3-
Ethylidene-1-tosylpiperidin-4-yl)(1H-indol-2-yl)methanone [(S)-9]. (R)-MeO-DTBM-
BIPHEP(AuCl)2 (8.1 mg, 5.0 μmol; 5 mol %) and AgSbF6 (3.4 mg, 0.01 mmol; 10 mol %) was 
dissolved in toluene (0.1 mL) and stirred for 10 min at room temperature. A solution of (Z)-11a 
(56.5 mg, 0.1 mmol) in toluene (0.4 mL) was transferred to the catalyst mixture. The mixture was 
stirred at room temperature for 17 h. The mixture was concentrated and purified on PTLC (silica 
gel) with hexane/EtOAc (3/1) to afford (S)-9 as a white amorphous solid {13.1 mg, 32% yield, 88% 
ee [HPLC, Chiralcel-OD-H column eluting under condition with 40% i-PrOH/n-hexane over 30 
min at 0.75 mL/min, t1 = 12.66 min (major isomer), t2 = 16.60 min (minor isomer)]}: []26D –2.1 (c 
0.92, CHCl3); IR (neat): 3334 (NH), 1641 (C=O), 1341 (S=O), 1159 (S=O); 1H NMR (500 MHz, 
CDCl3) δ: 1.71 (dd, J = 6.9, 1.7 Hz, 3H), 2.03-2.10 (m, 1H), 2.14-2.17 (m, 1H), 2.40 (s, 3H), 2.88 
(ddd, J = 12.3, 12.3, 2.9 Hz, 1H), 3.47-3.49 (br m, 1H), 3.71-3.74 (br m, 1H), 4.10-4.13 (br m, 1H), 
4.43-4.44 (br m, 1H), 5.71 (q, J = 6.9 Hz, 1H), 7.13-7.16 (m, 1H), 7.32-7.34 (m, 4H), 7.65 (d, J = 
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8.0 Hz, 2H), 7.70 (d, J = 8.0 Hz, 1H), 9.20 (br s, 1H); 13C NMR (125 MHz, CDCl3) δ: 13.3, 21.5, 
28.5, 41.1, 43.2, 52.3, 109.5, 112.1, 121.2, 123.1, 124.7, 126.7, 127.4, 127.7 (2C), 129.6 (2C), 
129.9, 133.4, 133.8, 137.3, 143.4, 192.7; HRMS (FAB) calcd for C23H25N2O3S (MH+) 409.1586, 
found 409.1585. 
 
3. Total Synthesis of (+)-Conolidine (Scheme 6). 
(S,E)-(3-Ethylidenepiperidin-4-yl)(1H-indol-2-yl)methanone (7). According to the reported 
method,26 removal of the tosyl group was carried out as follows: sodium (27.7 mg, 1.20 mmol) was 
added to a solution of naphthalene (193 mg, 1.50 mmol) in THF (1.5 mL) at room temperature and 
the mixture stirred for 30 min. The resulting dark green/blue solution (ca. 0.8 M in THF) was added 
dropwise to a solution of (S)-9 (49.2 mg, 0.12 mmol, 91% ee) in THF (1.2 mL) at 0 °C until dark 
green/blue color persisted. Saturated aqueous NaHCO3 was added and the solution was allowed to 
warm slowly to room temperature. The aqueous layer was then extracted with CH2Cl2 and the 
organic layers were washed with brine, combined, dried over K2CO3 and filtered. Concentration 
under reduced pressure and recrystallization from CH2Cl2–hexane afforded (+)-7 (18.5 mg, 60%): 
mp 205–210 °C; [α]28D = +41.0 (c 0.26, MeOH), comparable to the report by Bohn et. al. (2011)16: 
[α]25D = +45.0 (c 0.24, MeOH); IR (neat): 3345 (NH), 1627 (C=O); 1H NMR (500 MHz, CDCl3) δ: 
1.72 (dd, J = 6.9, 1.7 Hz, 3H), 1.87-1.95 (m, 1H), 2.20-2.22 (br m, 1H), 2.97-3.00 (br m, 1H), 3.15 
(ddd, J = 12.6, 12.6, 2.9 Hz, 1H), 3.33 (d, J = 12.6 Hz, 1H), 3.49 (s, 1H), 3.72 (d, J = 12.6 Hz, 1H), 
4.53-4.54 (br m, 1H), 5.54 (q, J = 6.7 Hz, 1H), 7.15-7.17 (m, 1H), 7.28 (s, 1H), 7.34-7.36 (m, 1H), 
7.43 (d, J = 8.0 Hz, 1H), 7.71 (d, J = 8.0 Hz, 1H), 9.16 (br s, 1H); 13C NMR (125 MHz, CDCl3) δ: 
13.0, 31.5, 43.0, 43.2, 53.1, 108.9, 112.1, 120.8, 121.0, 123.1, 126.3, 127.6, 134.4, 135.1, 137.1, 
193.6; HRMS (FAB) calcd for C16H19N2O (MH+) 255.1497, found 255.1490. 
(+)-Conolidine (1). According to the Bohn’s procedure,2 the amine (+)-7 (16.0 mg, 0.06 mmol), 
paraformaldehyde (6.8 mg, 0.23 mmol), and TFA (14.5 µL, 0.19 mmol) were dissolved in dry 
MeCN (1.2 mL) and the reaction mixture heated under reflux for 2 h. TFA (14.5 µL) was added and 
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the mixture was stirred for further 3 h. The mixture was concentrated in vacuo and the crude 
product was made basic with aqueous saturated NaHCO3 (to pH 9.0) and extracted with CH2Cl2 
three times. The resultant orange solution was dried over Na2SO4, concentrated in vacuo and 
chromatographed on NH2 silica gel (MeOH/CHCl3 = 99/1) to afford (+)-conolidine (1) (5.7 mg, 
34%, 84% ee [HPLC, Chiralcel-AD-H column eluting under condition with 80% i-PrOH/n-hexane 
over 25 min at 0.75 mL/min, t1 = 14.25 min (minor isomer), t2 = 16.95 min (major isomer)]): mp 
178–180 °C; [α]28D = +31.5 (c 0.24, CHCl3), comparable to the report by Kam et. al. (2004)1: [α]D = 
+32.0 (c 0.16, CHCl3), Bohn et. al. (2011)16: [α]27D = +28.1 (c 0.16, CHCl3); IR (neat): 2914 (NH), 
1634 (C=O); 1H NMR (500 MHz, CDCl3) δ: 1.51-1.52 (br m, 3H), 2.04-2.06 (m, 1H), 2.10-2.18 (m, 
1H), 3.06-3.13 (m, 1H), 3.30-3.33 (br m, 1H), 3.41 (ddd, J = 13.7, 8.6, 2.9 Hz, 1H), 3.85-3.88 (br m, 
1H), 3.97-3.98 (br m, 1H), 4.29 (d, J = 18.3 Hz, 1H), 4.78 (d, J = 18.3 Hz, 1H), 5.47 (q, J = 6.9 Hz, 
1H), 7.11 (ddd, J = 16.0, 8.0, 4.0 Hz, 1H), 7.32-7.37 (m, 2H), 7.57 (d, J = 8.0 Hz, 1H), 9.02 (br s, 
1H); 13C NMR (125 MHz, CDCl3) δ: 12.7, 22.9, 44.2, 48.1, 53.3, 55.0, 111.7, 120.1, 120.5, 120.8, 
122.9, 126.5, 127.9, 130.1, 133.5, 136.1, 193.5; HRMS (FAB) calcd for C17H19N2O (MH+) 
267.1497, found 267.1494. 
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